In the news
DiabAgent: Toward Agentic Physiological Control
arXiv cs.AI · Published · 3 min read
In 30 seconds
- What happened
- DiabAgent is a research framework for AI agents to control blood glucose in Type 1 diabetes through insulin dosing decisions using medical device tools.
- Why it matters
- Relevant for engineers building AI systems for medical device control, physiological simulation, or evaluating language models in closed-loop healthcare applications.
- Watch out
- Results use Claude Opus 5.5 with one-hour decision intervals on simulated patients; real-world safety, regulatory approval, and generalization remain unaddressed.
- agent
- agentic
- language model
- eval
The patterns behind this
Each one covers how the technique works, when it earns its cost, and where it breaks.
The Agent Architect
One pattern, one tradeoff, one production failure story. A short weekly briefing for people building agentic systems.
Weekly email, one-click unsubscribe. We only use your address to send the briefing.